Effects of the selective endothelin A (ETA) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage – preliminary results from a randomized clinical series

✍ Scribed by M. Barth; H.-H. Capelle; E. Münch; C. Thomé; F. Fiedler; P. Schmiedek; P. Vajkoczy

• Publisher: Springer Vienna
• Year: 2007
• Tongue: English
• Weight: 212 KB
• Volume: 149
• Category: Article
• ISSN: 0001-6268
• DOI: 10.1007/s00701-007-1249-3